Using RNA sequencing (RNA-seq), we identified and confirmed BCR–FGFR1 EMS in two patients, one presenting initially as AML (Fig. 1A) and the other as B-ALL (Fig. 1B). This evidence concerns the gene FGFR1 and acute myeloid leukemia.